By slowing digestion, this medication helps you feel full for longer, reduces cravings, and decreases overall hunger levels
Section 2: Understanding Semaglutide Section 2: Understanding Semaglutide Semaglutide represents a significant advancement in the management of type 2 diabetes and obesity, heralding a new era of glucagon-like peptide-1 (GLP-1) receptor agonists with potent therapeutic effects
Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc
Get Started Today Get Started Begin Your Regeneration Schedule a consultation with our medical team to learn if GHK-Cu copper peptide therapy is right for your skin health, tissue repair, and regenerative goals
Earlier this year (April 2025), Lilly reported positive Phase III results for orforglipron, an oral small-molecule (non-peptide) GLP-1 receptor agonist, for treating Type 2 diabetes and obesity
Long Term Considerations Retatrutide is most effective as an ongoing treatment rather than a temporary intervention